RenaissanceRe (NYSE: RNR) holder to sell 5,000 bonus shares

Rhea-AI Filing Summary

RenaissanceRe Holdings Ltd. (symbol RNR) reports a proposed sale of 5,000 shares of common stock through Merrill Lynch at One Bryant Park, New York. The shares have an aggregate value of $1,625,000, with company common shares outstanding of 41,551,893 and the securities listed on the NYSE. The shares to be sold were originally received as stock bonus awards on three dates in 2015 and 2016.

Key Figures

Shares proposed to be sold: 5,000 shares Aggregate market value of shares: $1,625,000 Shares outstanding: 41,551,893 shares +3 more

6 metrics

Shares proposed to be sold 5,000 shares Common stock to be sold through Merrill Lynch

Aggregate market value of shares $1,625,000 Value of 5,000 common shares proposed for sale

Shares outstanding 41,551,893 shares Common shares outstanding for the issuer

Stock bonus grant 1 1,825 shares Common shares received as stock bonus on 12/30/2015

Stock bonus grant 2 1,100 shares Common shares received as stock bonus on 02/18/2016

Stock bonus grant 3 2,075 shares Common shares received as stock bonus on 03/03/2016

Key Terms

Form 144, stock bonus, aggregate value

3 terms

Form 144 regulatory

"RNR's Form 144 filing discloses a proposed sale of shares"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

stock bonus financial

"The shares were acquired through stock bonus awards on three dates"

aggregate value financial

"The filing reports an aggregate value of $1,625,000 for the shares"

FAQ

What does RNR's Form 144 filing disclose about common stock sales?

The filing reports a proposed sale of 5,000 shares of RNR common stock with an aggregate value of $1,625,000. These shares are listed on the NYSE and were originally received as stock bonus awards.

How many RNR shares are outstanding according to this Form 144?

The Form 144 states that 41,551,893 shares of RNR common stock are outstanding. This figure provides context for the relative size of the proposed 5,000-share sale reported in the notice.

What is the value of the RNR shares proposed to be sold under this Form 144?

The notice lists an aggregate value of $1,625,000 for the 5,000 RNR common shares proposed for sale. This value is tied to the shares to be sold through Merrill Lynch as referenced in the filing.

How were the RNR shares in this Form 144 originally acquired?

The shares were acquired through stock bonus awards on three dates: 1,825 shares on 12/30/2015, 1,100 shares on 02/18/2016, and 2,075 shares on 03/03/2016, all from the issuer.

On which exchange are the RNR shares in this Form 144 listed?

The shares referenced in the Form 144 are listed on the NYSE. The filing ties the proposed sale of 5,000 common shares to the company’s common stock traded on that exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 01:21 PM Accepted by SEC EDGAR 08/17/2026 - 01:20 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch One Bryant Park 28th Fl New York NY 10036	5000	1625000	41551893	08/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/30/2015	Stock Bonus	Issuer			1825	12/30/2015	Cash
Common	02/18/2016	Stock Bonus	Issuer			1100	02/18/2016	Cash
Common	03/03/2016	Stock Bonus	Issuer			2075	03/03/2016	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)